To understand myosin regulation of epithelial permeability. METHODS: 11tis was an experimental study, using human cemical epithelial cells CaSki. Et1d points were paracellular permeability (determined in terms of transepithelial electrical resistance); non-muscle myosin-JI-B (NMM-II-B) cellular localization; NMM-II-B phosphorylation status; NMM-II-B-actin interaction (determined in vitro by the immunoprecipitation-immunoreactivity method); and N1HJ'v1-II-B filamentation (determined in vitro using purified NMM-II-B filaments itt terms cif filaments disassembly! assembly ratios.
via the intercellular space (paracellular route). Human cervical cells form relatively leaky types of epithelia, and their overall permeability properties are determined by the paracellular route. Subsequently, the paracellular (intercellular) pathway is the major route of transcervical epithelial transport.
Free movement of water and solutes in the paracellular pathway is restricted by the resistance of the tight junctions (RTJ) and by the resistance of the lateral intercellular space (Ru5), in series. 1 • 2 In most epithelia, the RTJ detennines the overall paracellular resistance, but in leaky epithelia, such as the vaginal and cervical epithelia, the contributions of the Rus to the total resistance can be significant. 3 The RTJ is detennined by the tight junctional complexes that are usually located at apical regions of the cells (facing the lumen) above the zonula adherence and desmosomes. The tight junctions extend in a belt-like manner around the perimeter of each epithelial cell and connect neighboring cells, thereby effectively occluding the intercellular space. The resistance to the free movement of molecules that is associated with the tight junctions is considered a high-resistive element and is tenned the RTJ· The second mechanism that gates the intercellular (paracellular) space is a resistance that is determined by the proximity of neighboring epithelial cells. Thus, cells that are closer to each other result in fom1ation of a lesser lateral intercellular space, while cells that are pulled apart result in formation of a greater lateral intercellular space. The Rus is considered a low-resistive element, and it can be modeled by Poiselle's law as a series of narrow tubes so that the resistance of each tube depends on the length of the intercellular space from the tight junctions to the basal lamina (height of the epithelial cells), and reciprocally on the fourth power of the radius of the intercellular width. Mechanistically, the latter is detem1ined by the proximity of the plasma membranes of neighboring cells such that even minor changes in cell volume can affect the lateral intercellular space and markedly affect the
Rus·
The geometry of the intercellular space is detem1ined reciprocally by the \'.':idth and shape of the epithelial cells that define this space. The shape of epithelial cells depends mainly on the elasticity of the actin cytoskeleton: cells expressing a rigid cytoskeleton will change their shape less readily in response to stimuli than cells expressing a dynamic cytoskeleton. The actin cytoskeleton can be modulated by regulation of actin polymerization. Formation of G-actin-dominated cytoskeleton decreases the Rus• while actin polymerization (F-actin) produces rigid cytoskeleton and increases Rus· 4 ' 5 The actin cytoskeleton can be also modulated by regulation of myosin filaments. 6 Myosins are proteins that interact with actin and hydrolyze adenosine triphosphate (A TP) to generate force. Most of the knowledge about myosin-actin interaction has been derived from studies in muscle cells? Studies in non-muscle cells showed that myosin-II, the prototypical twoheaded myosin, regulates actin organization into filaments that maintain the shape of cellular structures or coordinate contraction for locomotion and cell division? The non-muscle myosin-II, a subclass of myosin-II, 8 was shown to play a role in epithelial cell attachment and intercellular communications. 9 In humans, the state of myosin-ll activation regulates para cellular permeability in kidney cells, 10 ' 11 and abrogation of paracellular resistance leads to backleak of glomerular filtrate? In patients with inflammatory bowel disease, colonic epithelial myosin light-chain kinase (MLCK) expression and enzymatic activity were found to be increased, suggesting that MLCK up-regulation may contribute to barrier dysfunction and the pathogenesis inflammatory bowel disease. 12 These reports suggest a role for the cytoskeletal acto-myosin cortex in the regulation of epithelial cell shape and paracellular resistance. However, relatively little is known about the cellular and molecular mechanisms involved; very few studies researched the field of myosin regulation of epithelial permeability, and most mechanistic studies in the field were published more than a decade ago.
Li and Gorodeski
The objective of the present study was to better understand how the acto-myosin regulates the rigidity of the cytoskeleton in epithelial cells, and hence the epithelial paracellular resistance. The experiments focused on the hexameric non-muscle myosin-II types A and B that are composed of two pairs of light chains that associate with two pairs of heavy chains, and which are most abundant in epithelial cells. 13 • 14 The experimental model was the cultured human epithelium CaSki, which has been previously characterized as a relatively leaky type of epithelium. 15 ' 16 The results suggest that non-muscle myosin-liB (NMM-ll-B) filaments are constitutively and directly phosphorylated by casein kinase-II (CK2), and dephosphorylated through the concerted actions of Rhoassociated kinase (ROCK)-regulated myosin heavy-chain phosphatase. Increased phosphorylation is associated with decreased filamentation of NMM-II-B filaments in vitro and with lesser myosin-actin interaction. The results also suggest that decreased myosin-actin interaction may lead to formation of a dynamic cytoskeleton, resulting in a decrease in the Rus·
METHODS

Cell Cultures
Experiments used the previously characterized cultured CaSki cell model, which is a stable line of transformed cervical epithelial cells. 15 ' 16 CaSki cells were grown and subcultured in culture dish in RPMI-1640 supplemented with 8% fetal calf serum (FCS), 0.2% NaHC0 3 , nonessential amino acids, L-glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 mg/mL), and gentamycin (50 jJ.g/mL) at 37C in a 91% 0 2 /9% C0 2 humidified incubator, and routinely tested for mycoplasma. Experiments were done on cells grown on cover-slips or on filters. For filter experiments, cells were plated on Anocell (Anocell-10) filters (Oxon, UK, obtained through Sigma Chemicals, St. Louis, MO), which are ceramicbase filters with a pore size of 0.02 jJ.m width and 50 jJ.m depth. Filters were coated on their upper (luminal) surface with 3 to 5 jJ.g/cm 2 collagen type IV. Filter experiments involved treatments with drugs to both the luminal and subluminal solutions.
Changes in paracellular resistance were determined in tem1s of changes in the transepithelial electrical resistance (RTE) as described previously. 17 Briefly, cells on filters were shifted to a modified Ringer buffer and mounted in a modified Ussing chamber. Drugs were added to both the luminal and subluminal solutions, and changes in paracellular permeability were determined in terms of changes in RTE from successive measurements of the transepithelial potential difference (LlPD, lumen-negative), and the transepithelial electrical current (Ill, obtained by measuring the current necessary to clamp the offSet potential to zero, and normalized to the 0.6-cm 2 surface area of the filter) as RTE = LlPD/ IlL Changes in the tight junctional resistance (RTJ) were determined in terms of changes in the relative mobilities of Na + and Clin the intercellular space (UCl/UNJ from measurements of the dilution potentials. The experimental design of the electrophysi-ologic measurements, including calibrations and controls, the significance of the ~PD and ~I, and the conditions for optimal determinations of RTE across low-resistance epithelia, eg, CaSki, were described and discussed. 17 lmmunostaining, light microscopy, and fluorescence microscopy were described previously. 18 Briefly, following treatments, cells attached on cover-slips or on filters were washed with cold phosphate-buffered saline (PBS) and fixed in methanol; blocked with 3% bovine serum albumin (BSA)/PBS/ 0.2% Triton X-100 for 30 minutes; incubated with primary antibodies overnight at 4C; washed three times with PBS; and incubated with secondary antibodies attached with Alexa Fluor 488 (donkey anti-rabbit IgG) or Alexa Fluor 594 (goat antimouse). Nuclei were stained with DAPI (Vector, Burlington, CA). In some experiments, cells were incubated with horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG, and heavy and light chain peroxidase, and the reaction was visualized by Fast-Red (Dako, http:/ /www.dakocytomation.com).
Cell-fractionation by the freeze/thaw method and Western immunoblotting were described previously. 18 Confirmation of the separation efficiency of the membrane-enriched fraction was determined by blotting with anti-occludin antibody (tight junction plasma-membrane protein). Likewise, confirmation of separation efficiency of the cytosolic fraction was determined by blotting with anti-GAPDH antibody. Aliquots, normalized to 15 j.Lg protein, were fractionated by 6% to 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and blotted by Western analysis, and bands were analyzed semi-quantitatively by densitometry. lmmunoprecipitation/immunoblotting assays used standard techniques that were recently described. 18 Phosphorylation assays have been described previously. 18 Briefly, cells on filters were shifted to phosphate-free Dulbecco's modified Eagle medium (DMEM) containing 10mM HEPES, pH 7.4 at 37C, and treated with 100 j.LCi/ml e 2 P]orthophosphate (PerkinElmer Life Sciences, Boston, MA) plus 1 j.Lg/mL microcystin L-R (Calbiochem, San Diego, CA). After treatments, cells were washed with ice-cold PBS, lysed in lysis buffer, and processed by immunoprecipitation with antinon-muscle myosin-II heavy-chain-B (anti-NMM-II-HC-B) antibody. Samples containing equal amounts of protein were resolved on 10% polyacrylamide gels and dried under vacuum. Radioactive bands were visualized by Phosphorlmager (Molecular Dynamics [Amersham], Piscataway, NJ) and by exposure to x-ray film.
Extraction and purification of NMM-II-B filaments were done using a modification of existing methods. 19 · 20 All steps were done at 4C. Cells pooled from five to seven filter inserts were used to generate membrane-enriched and cytosolii:: fractions. Fractions were incubated overnight with anti nonmuscle myosin-II heavy-chain-A (NMM-II-HC-A) antibody to immunoprecipitate the non-muscle myosin-II-A (NMM-II-A) filaments. Pansorbin was added to the immununoprecipitates for 2 hours and the Pansorbin/anti-NMM-II-HC-A antibody/NMM-II-A complexes were pelleted by centrifugation at 25,000g for 15 minutes. Since the amount of NMM-II-B remaining in the pellets was minimal (<5%, not shown), the pellets were discarded. The supernatants were washed three times with buffer containing 0.5 M NaCl, 50 mM MOPS, pH 7.4, and 0.1 mM EGT A to disassociate oligomerized filaments and to remove nonspecifically bound proteins. Supernatants were resuspended in 0.2 mL of wash buffer containing 50-fold molar excess of the peptide used to generate the anti-human NMM-II-A antibody (GKADGAEAKPAE, corresponding to the C-terminus of the human NMM-II-HC-A), and after 2 hours of incubation on ice, mixtures were spun at 35,000g for 15 minutes and the supernatants containing the released NMM-II-B were dialyzed against several changes of wash buffer and concentrated to a volume of about 250 j.LL by washing in Centricon 100 (Amicon, Houston, TX).
Dynamic disassembly/assembly ofNMM-II-B filaments was determined in real-time by measuring turbidity at 340 nm. Aliquots of purified NMM-II-B filaments extracted from membrane and cytosolic fractions (25 j.LL of 5 j..t.M) were transferred to a cuvette of 2 mm width that was placed in a spectrometer, containing 0.3 mL of solution composed of 10 mM imidazole-HCl (pH 7.5), 2 mM EGTA, 10 mM NaCl, and 2.5 mM Mg 2 + at room temperature. Under these conditions, NMM-II-B filaments assemble into homodimers, and the absorbance at 340 nm is close to 1.0. 21 • 22 Disassembly of NMM-II-B filaments into monomers was induced by increasing Ca 2 + concentration in the solution to 1.2 mM by adding aliquots from a concentrated CaC1 2 solution. The end point was the half-time (t 1 n) of the decrease in absorbance from 1.0 to 0 upon adding Ca 2 +, calculated by fitting the data to an exponential. The reversibility of the effect (ie, filaments assembly) was determined by adding EGTA to chelate Ca 2 +. 3  4  3  3  3  3  3 CaSki cells on filters were treated with the indicated drugs as described in Figure 1 . A TP was added at 10 j.LM and determinations were made after 10 minutes, at the peak of the increase in RrE (phase II response). L'i EGTA was added at 0.6 mM to lower free Ca 2 +in the extracellular buffer to 0.6 mM, and detenninations were made after 10 minutes, at the trough of the decrease in RTE· 15 CO : : : : ; ; : cytochalasin-D;
y -2 = y -27632. * P < .05-.01 compared to baseline.
In Vitro NMM-11-B Filament
Assembly Assay
Purified NMM-Il-13 filaments at concentrations of 1 to 500 ~J-g/mL (about 20 nM to 10 j.LM) were incubated with 2.5 mM Mg 2 + and 10 mM NaCl at 4C in the presence of 10 mM imidazole-HCl (pH 7.5) and 0.1 mM Ca 2 + to induce filament assembly. At the completion of incubations, samples were centrifuged at 25,000g for 30 minutes at 4C, and the protein content in the supematant (ie, non-dimerized NMM-Il-B) was measured and expressed per total protein measured before centritugation as the percentage non-dimerized NMM-II-B.
To ascertain complete recovery of non-dimerized filaments, aliquots from the supematant were centrifuged at 90,000g for 20 minutes. Assays where sediment was found, indicating inappropriate separation of the monomers from the oligomers, were omitted from analysis (<5% of assays). The degree of NMM-II-B filament assembly was expressed in terms of the critical concentration of NMM-11-B necessary to induce Li Md Gorodeski dimerization from the curve of [% non-dimerized NMM-II-B] vs [added protein]. The concentration of NMM-Il-B that induced maximal dimerization was defined as the critical concentration of NMM-II-13 necessary for dimerization. Some experiments studied the direct effect of CK2 on NMM-Il-B filament assembly. ln those experiments, purified NMM-Il-B filaments were exposed to 0.2 ~J-g per 100 f1L of purified CK2 from rat liver (Sigma; dissolved in PBS), or to heatinactivated (65C) CK2. Cellular G-actin content was detennined by the DNase-I inhibition assay as previously described. 4 ' 5 Briefly, cells on filters were lysed in situ and DNase-l activity in the lysate was assayed by measuring DNase-1-dependent degradation ofDNA. Total actin was measured by the guanidine-HCl method after depolymerization of F-actin to monomeric G-actin.
Cellular DNA and total protein were measured as described previously. 23 
Antibodies
Mouse monoclonal antihuman [3-actin antibody was from Zymed Laboratory Inc (San Francisco, CA). Rabbit polyclonal antihuman NMM-Il-HC-A antibody (PRB-440P) and its antigenic peptide, and the anti-human NMM-II-HC-B antibody (PRB-445P) were from Covance Research Products (Berkeley, CA). Mouse monoclonal antihuman phosphoserine, phosphothreonine, and phosphotyrosine PY20 and P99 antibodies were from Transduction Laboratories (BD Biosciences, San Jose, CA). The antibodies were used according to the manufacturers' instructions.
Chemicals and Supplies
All chemicals, unless specified otherwise, were obtained from Sigma Chemical. 5,6-dichloro-1- (DRB) and Y -27632 ware obtained from Calbiochem, La Jolla, CA}.
Statistical Analysis
Data are presented as means (±SD) and significance of differences among means was estimated by analysis of variance (ANOVA) using GB-STAT (Dynamic Microsystems Inc., Silver Spring, MD).
RESULTS
Modulation of RTE
Baseline RTE across CaSki cells was about 20 n . en} ( Figure 1 , Table 1 ), and is in the range considered characteristic of "leaky" epithelia. To understand to what degree the stability of the cytoskeletal acto-myosin determines the paracellular resistance, CaSki cells were treated with drugs previously reported to affect actin status and phosphorylation of non-muscle myosin filaments in other types of cells. Drugs were used at doses that produced submaximal effects, and lengths of treatments were chosen so that upon removal of the drugs (by washes) RTE levels returned to baseline within 1 to 24 hours (not shown). The reversibility of the effects assured that observed changes in RTE were not the result of toxic effects of the drugs. The effects ofactin modulators are shown in Figure 1 and summarized in Table 1 . Treatment with phalloidin increased RTE to 50 n. cm 2 (Figure 1 , Table 1 ). Treatment with cytochalasin-D decreased RTE to 3 n. cm 2 , and in the presence of phalloidin the effect of cytochalasin-D was attenuated, J Soc Gynecol lnvestig Vol. 13, No. 8, December 2006 583 with RTE decreasing only to 10 n . cm 2 (Figure 1 ' Table 1 ).
These results confirm previous studies 45 showing that modulation of actin polymerization affects the paracellular permeability.
One of the objectives of the current study was to understand how myosin regulates the paracellular permeability. Unpublished results from the laboratory showed that CaSki cells express MLCK, and that treatments with Ca 2 + -calmodulin modulators change phosphorylation level of the regulatory component of MLCK (not shown). In the present study treatment with the calmodulin inhibitor W-7 or with the Ca 2 + I calmodulin-dependent protein kinase-II (CaMK-II) inhibitor KN-93 produced only small and short-lived (<1 minute) transient changes in RTE (not shown), suggesting that in CaSki cells phosphorylation of the regulatory component of myosin light chain by the calcium-calmodulin-dependent MLCK 8 · 24 does not significantly modulate the RTE· Similar to W-7 and KN-93, other protein kinase inhibitors, including tryphostin 25, genistein, and SB203580, had no significant effect on RTE (not shown). In contrast, DRB, Y -27632, and okadaic acid significantly modulated the resistance. Treatment with DRB, a cell-permeable inhibitor of CK2, 25 increased RTE to 35 n. cm 2 (Figure 1 , Table 1 ).
Treatment withY -27632, an inhibitor ofROCK, 26 decreased RTE to 10 n. cm 2 (Figure 1 , Table 1 protein phosphatase activity, 27 decreased R TE to 12 n. cm 2 (Figure 1 ). Combined treatments of okadaic acid plus Y -27632 produced changes in RTE suggestive of additive effects (Figure 1 ). Neither okadaic acid, Y -27632, nor DRB affected phalloidin (10 ng/mL) increase in RTE• and DRB did not affect cytochalasin-D decrease in RTE; however, both okadaic acid and Y -27632 inhibited the DRB-induced increases in RTE (Figure 1 ).
Cellular Distribution of Non-Muscle Myosins
Lack of an effect by W-7 and KN-93, together with the changes in RrE induced by DRB, Y-27632, and okadaic acid suggested modulation of phosphorylation of myosin heavy chains. 28 Since relatively little was known about the myosin composition in CaSki cells, we studied expression of myosins with emphasis on NMM-II-A and NMM-II-B filaments, the prototypical two-headed myosins in non-muscle cells. Immunostaining of CaSki cells attached on filters with anti-NMM-II-HC-A or NMM-II-HC-B antibodies revealed different cellular distribution patterns of the two myosins. NMM-II-A was found predominantly in the cytoplasm and perinuclear regions (Figure 2 , Control, second column), while NMM-II-B was found predominantly in submembranous areas (Figure 2 , Control, fifth column, and Figure 3 ). Western immunoblots confirmed the differential cellular distribution of NMM-II-A and NMM-II-B: NMM-II-A was found mainly in the cytosolic fraction while NMM-II-B was found predominantly in the membrane-enriched fraction ( Figure 4A ).
To determine whether NMM-II-A and NMM-II-B interact with actin, two experiments were performed. The first experiment used the co-immunostaining technique for actin and the myosins. Figure 2 (Control, columns 1 and 4) and Figure 3 show 13-actin inmmnoreactivity decorating the cortical cytoskeleton frame, and a more diffuse staining in the cytoplasm and perinuclear regions. Co-staining with anti-13actin plus anti-NMM-II-HC-A antibodies revealed some interaction between actin and NMM-II-A in the cytoplasm and perinuclear regions (Figure 2, Control, column 3) . Co-staining with the anti-13-actin plus the anti-NMM-II-HC-B antibod-ies, on the other hand, revealed a pronounced interaction between actin and NMM-II-B in the cortical cytoskeleton frame (Figure 2 , Control, column 6). The second experiment used the technique of co-immunoprecipitation and immunoblotting. Total homogenates and cell fractions of CaSki cells were immunoprecipitated with anti-!3-actin antibody and immunoblotted with anti-NMM-II-HC-A or anti-NMM-II-HC-B antibodies. NMM-II-A immunoreactivity was found predominantly in the cytosolic fraction ( Figure 4B ) and NMM-II-B immunoreactivity in the plasma-membraneenriched fraction ( Figure 4C ). Both types of myosins associated in vitro with actin ( Figure 4B and C) . Collectively, the results in Figures 2 through 4 suggest that in CaSki cells the cortical cytoskeleton frame is composed predominantly of NMM-II-B, and that NMM-II-B associates with actin.
Modulation of the Cortical
Acto-Myosin Frame EFFECTS OF PHALLOIDIN AND CYTOCHALASIN-D. Treatment with phalloidin did not significantly affect the cellular distribution and content of actin (Figures 2 and 5) , NMM-II-A (Figure 2 ), or NMM-II-B (Figures 2, 3 , and 5). Treatment with cytochalasin-D, on the other hand, resulted in disorganization of the cortical cytoskeleton frame, and the actin and NMM-II-B immunoreactivities in the cortical frame showed speckled, granular staining and breakage points at submembranous regions (Figures 2 and 3b , c, e, and f). Cytochalasin-D had little effect on the cellular content of actin ( Figure 5 ) and NMM-II-B ( Figures 4C and 5 ), but it decreased NMM .. II-A content ( Figure 4B ). Cytochalasin-D also decreased the actin-NMM-II-A co-immunoprecipitated prod- uct in total homogenates and in the cytosol, probably reflecting the decreased content of cellular NMM-II-A ( Figure 4B ). In contrast, cytochalasin-D decreased the actin-NMM-II-B coimmunoprecipitated product in the membrane-enriched fraction, and increased it in the cytosolic fraction ( Figure 4C ). Co-treatment with phalloidin did not significandy modulate cytochalasin-D effects (Figures 3g and h NMM-II-B co-immunoprecipitated product in total cells homogenates ( Figure 5 ). Co-treatment with DRB attenuated the effects ofY -27632 ( Figures 2, 3q and r, and 5). Treatment with okadaic acid had no significant effect on the cortical cytoskeletal frame (Figure 2 ).
Multi-Drugs Effects
Co-treatment with DRB did not modulate cytochalasin-D effects on actin and NMM-II-B (Figure 2) . In contrast, Y -27632 effects were inhibited by co-treatment with phalloidin (Figures 2, 3q and r, and 5) .
Collectively, the results in Figures 2 through 5 indicate that cytochalasin-D and Y -27632 induced disorganization of the cortical cytoskeletal frame and decreased the actin-NMM-II-B co-immunoprecipitation. Phalloidin and DRB attenuated the effects ofY -27632, but neither phalloidin nor DRB modulated the effects of cytochalasin-D.
In view Df the findings that in CaSki cells NMM-II-B is the predominant myosin of the cortical cytoskeleton frame, all subsequent experiments focused on the NMM-II-B.
Phosphorylation of NMM-II-B
TheY -27632 and DRB data in Figures 1 through 5 suggested the involvement of ROCK and CK2, respectively, in the modulation ofNMM-II-B. One of the mechanisms by which ROCK and CK2 modulates NMM-II-B function is through phosphorylation of myosin heavy chains. 28 Table 2 . Readings were made about every 10 seconds. (C) Changes in NNM-11-B filaments assembly detcnnined in terms of the critical concentration ofNMM-11-B filaments preparations necessary to induce oligomerization in vitro. The experiments arc described in the Methods and Results, and data are summarized in Table 3 . CaSki cells on filters were treated with the indicated drugs as described in Figure 1 . NMM-ll-B filaments were extracted, purified, and used for dynanlic disassembly/ assembly assays (see Methods).
* P < .05-.01 compared to controL phosphorylated at baseline conditions, and that treatment with DRB inhibited baseline NMM-II-B phosphorylation while treatments vvith Y -27632 and okadaic acid increased baseline NMM-Il-B phosphorylation ( Figure 6A ). Since none of the treatments had a significant effect on the cellular content of NMM-II-B ( Figures 5 and 6) , it was possible to evaluate the changes in NMM-II-B phosphorylation status semi-quantitatively using densitometry ( Figure 6B ). Thus, DRB inhibited NMM-II-B phosphorylation by about two thirds, while Y -27632 and okadaic acid increased NMM-II-B phosphorylation five-to sixfold. Co-treatment with DRB had no significant effect on the phosphorylation of NMM-II-B induced by Y -27632 or okadaic acid ( Figure 6A and B) .
To determine what residues of the myosin are phosphorylated, cell lysates were immunoprecipitated with anti-phosphoantibodies, and immunoblotted vvith the anti-NMM-II-HC-B antibody. Treatments vvith Y -27632 and okadaic acid increased phosphoserine and phosphothreonine immunoreactivities compared to baseline conditions, while treatment with DRB decreased the phosphoserine and phosphothreonine immunoreactivities (Figure 7) . Co-treatment with DRB had little effect on the effects of Y -27632 and okadaic acid (Figure 7) . Treatment with phalloidin had no effect on baseline phosphorylation of NMM-II-B, and co-treatment vvith phalloidin had no effect on the increase in phosphorylation induced by Y -27632. Treatment with cytochalasin-D increased baseline phosphorylation of NMM-II-B by about half (Figure 6A  and B) .
Collectively, the results in Figures 6 and 7 show that Y -27632 and okadaic acid increased, and DRB decreased NMM-II-B phosphorylation at serine and threonine sites.
Modulation of NMM-II-B Homodimerization: Treatments In Vivo
Optimal binding ofNMM-II-B to actin requires the myosin in its homodimeric form. 20 -22 • 2~ To understand whether the effects of Y -27632 and DRB shown in Figures 1 through 7 involve modulation of NMM-II-B oligomerization, NMM-II-B filaments extracted from cells treated with these drugs were purified and assayed for homodimerization in vitro. Figure 8 shows the methodology used in the present study. The extraction and purification procedure described in Methods yielded a single band, which immunoreacted vvith the CaSki cells on filters were treated with the indicated drugs as described in Figure 1 . NMM-1!-B filaments were extracted, and assembly of NMM-ll-B filaments was detennined in terms of the critical concentration of filaments necessary for homodimerization (see Methods). OA = okadaic acid; Ph = phalloidin.
* P < .05-.01 compared to control.
anti-:-NMM-II-HC-B antibody but not with the anti-NMM-II-HC-A antibody ( Figure SA) . Figure 8B shows an example of real-time changes in NMM-II-B oligomerization: cl+ (high-salt)-induced disassembly, and low-Ca 2 + -induced assembly (homodimerization) of NMM-II-B filaments. Table 2 summarizes results using that technique with preparations obtained from cells treated in vivo vvith Y -27632 and DRB. Ca 2 + -induced disassembly ofNMM-Il-B filaments was faster, and low-Ca 2 + -induced assembly was slower in preparations obtained from cells treated withY -27632 compared to control cells. DRB tended to inhibit disassembly and enhance assembly of NMM-II-B filaments, while co-treatment vvith DRB inhibited the effects ofY-27632 ( Table 2) . The experiments in Figure 8C and Table 3 used a secondary method to determine modulation of NMM-Il-B filaments assembly, in terms of the critical concentration of NMM-II-B filaments necessary to induce homodimerization in vitro. The critical concentration of NMM-II-B filaments was higher in preparations obtained from cells treated in vivo with Y -27632 or okadaic acid, and lower in preparations obtained from cells treated in vivo with DRB, compared to control cells (Table 3 ). CaSki cells on filters were treated in vivo with one or more of the indicated agents (as in Figure 1) (filled bars) . At the completion of treatments NMM-II-B filaments were extracted, warmed to 30C, and exposed in vitro for 6 hours at 30C to CK2 (0.2 J.l-g/100 J.1L). Assembly of NMM-II-B filaments was determined in terms of the critical concentration of filaments necessary for homodimerization as described in the Methods and Figure 8C These results resemble those in Figure 8B and Table 2 , and indicate that treatments with Y -27632 and okadaic acid decrease NMM-Il-B filamentation, while DRB increases NMM-II-B filamentation.
Co-treatments in vivo with Y -27632 plus DRB, with Y -27632 plus okadaic acid, or with DRB plus okadaic acid resulted in critical concentrations levels of NMM-II-B filaments that were similar to those in control cells (Table 3) , suggestive additive effects. One of the conditions for optimal myosin-actin interaction in striated and smooth muscle cells is the presence of actin in its polymerized form (ie, F-actin). 30 To test whether in the epithelial CaSki cells actin polymerization status affects NMM-II-B filamentation, the above experiments were repeated using preparations obtained from cells treated with phalloidin, to stimulate actin polymerization, 5 or with sodium nitroprusside (SNP), to stimulate actin de-polymerization. 4 The results in Tables 2 and 3 show that the assembly and disassembly rates of NMM-II-B filaments were not significantly affected by prior treatments with phalloidin or SNP.
Modulation of NMM-II-B Homodimerization: Treatments In Vitro
The results in Tables 2 and 3 indicate that treatment with the CK2 inhibitor DRB enhanced NMM-II-B filamentation, suggesting a role for CK2 as inducer of disassembly ofNMM-II-B filaments in vivo. To better understand the effects of CK2 on NMM-II-B filamentation, extracted NMM-II-B filaments were exposed in vitro to CK2, and the critical concentration of NMM-Il-B filaments was determined. Exposure to CK2 in vitro, but not to heat-inactivated CK2, increased the critical concentration of NMM-II-B filaments. Exposure in vitro to DRB, okadaic acid, or Y -27632 had no significant effect, but co-administration of DRB blocked the CK2 effect. Neither Y -27632 nor okadaic acid had any additional effect to that of CK2 (Table 4 ). These results suggest that CK2 directly inhibits NMM-II-B filamentation.
The combined effects of the in vivo and in vitro treatments are shown in Figure 9 . The data of the in vivo treatments were similar to and confirmed the data in Tables 2 and 3 
Actin-Dependent Versus Myosin-Dependent Modulation of the Rus
One of our objectives was also to better understand how modulation of the NMM-II-B affects the paracellular resistance. Changes in the paracellular resistance can be the result of modulation of the RTJ or the Rus Neither phalloidin, Y -27632, nor DRB had any significant effect on the relative mobilities of cr· to Na + across the epithelium (uc/uNa• Table 1 ). The positive controls for those experiments were increases in RTE induced by A TP and decreases in RTE induced by lowering extracellular calcium with EGTA, which, as previously reported, 17 were associated with decreases and increases, respectively, in the ratio of uc/uNa (Table 1) . Therefore, the resistance effects of phalloidin, Y -27632, and DRB do not involve changes in RTJ• and most likely involve modulation of the Rus· The cytochalasin-D-induced decrease in resistance, on the other hand, was associated with an increase in uc/uNa (Table 1 ), suggesting abrogation of the RTJ· The mechanism of phalloidin regulation of the Rus through inhibition of F-acrin de-polymerization is well established.5 The experiment in Figure 1 showed that both phalloidin and DRB produced a non-additive increase in resistance, and suggested initially that phalloidin and DRB utilize a common cellular mechanism. To gain better understanding in the matter, the experiment was repeated using non-saturating doses of phalloidin. Co-treatment with near maximal concentration ofDRB (10 j..t.M) plus phalloidin at the low concentration of 1 ng/mL produced greater increases in resistance than each of the drugs alone (Figure lOA ). In contrast, to-treatment with a maximal concentration ofDRB plus phalloidin at a concentration of 10 ng/mL produced a nonadditive effect, similar to that described in Figure 1 . Cotreatment with A TP produced additional increases in resistance, regardless of the concentrations of phalloidin used (Figure lOA) , indicating that the effect of ATP is additive to that of DRB and phalloidin.
The result in Figure lOA suggested that the effects ofDRB and phalloidin are mediated by different mechanisms. To test this hypothesis more directly, the effects ofDRB on resistance were compared with those of SNP. SNP reportedly decreases the Rus by de-polymerization of F-actin to G-actin. 4 The results in Figure lOB show that treatment with SNP decreased the resistance independent of the increase in resistance induced by DRB. Figure lOB also confirmed 4 · 5 that treatment with SNP increased cellular G-actin; in contrast, DRB had no effect on cellular G-actin.
DISCUSSION
The mam objective of the study was to understand how myosin regulates the rigidity of the cytoskeleton in epithelial cells. The results in CaSki cells, similar to findings in other non-epithelial non-muscle cells, 31 -34 showed that the cortical acto-myosin is composed predominantly of NMM-II-B.
NMM-II-B was constitutively phosphorylated, and the degree of phosphorylation could be modulated by treatments with DRB, Y -27632, and okadaic acid. Treatment with the ROCK inhibitorY -27632 induced effects that correlated in time and were reversible upon withdrawal of treatment (not shown). Those included a decrease in Ru 5 , disorganization of the cortical acto-myosin, decreased co-immunoprecipitation of NMM-II-B with actin, increased phosphorylation of NMM-II-B at threonine and serine residues, and decreased NMM-II-B filamentation in vitro. It is possible that these are unrelated epiphenomena. On the other hand, it is possible that these effects are related, and represent a novel cellular cascade by which increased phosphorylation of NMM-II-B results in decreased filamentation, decreased interaction with actin, and de-stabilization of the cortical acto-myosin frame. These effects may lead to formation of a dynamic cytoskeleton and subsequently to decreased Rus·
One of the objectives of the study was to understand the mechanisms that regulate NMM-II-B filamentation. Both Y -27632 and the nonspecific phosphatase inhibitor okadaic acid induced an increase in the phosphorylation ofNMM-II-B at threonine and serine residues and inhibited NMM-II-B filamentation. However, okadaic acid blocked Y -27632 inhibition of filamentation, suggesting that the effects ofY -27632 depended on the action of a phosphatase. The Y -27632 and okadaic acid effects in the epithelial CaSki cells resemble effects in smooth muscle cells where calcium-dependent phosphorylation of myosin-II filaments involves ROCK-mediated inhibition of myosin heavy-chain phosphatase. 35 · 36 Since activation ofRho-related proteins modulates the cytoskeleton even in low organisms such as protozoa, 37 • 38 the present results suggest that ROCK-related modulation of myosin heavychain phosphatase is a general mechanism that determines the rigidity of the cytoskeleton among species and cell types. According to this hypothesis, myosin heavy-chain phosphatase de-phosphorylates the NMM-II-HC-B directly, while the ROCK effect is secondary, through phosphorylation and inhibition of the myosin heavy-chain phosphatase.
The present results also suggest that CK2 modulates NMM-II-B filamentation directly. This conclusion is supported by the findings that treatment with the CK2 inhibitor DRB decreased the phosphorylation of NMM-II-B at threonine and serine residues. DRB increased NMM-II-B filamentation, NMM-II-B-actin co-immunoprecipitation, and the Ru 5 , and it attenuated the Y-27632 effects. CK2 blocked NMM-II-B filamentation in vitro, and the effect could be blocked by co-administration of DRB, possibly by competing with CK2 for target binding sites. Furthermore, the administration of CK2 in vitro to NNM-II-B preparations of NNM-II-B decreased filamentation irrespective of the degree of filamentation detennined by prior treatments of the cells in vivo. Collectively, the data indicate that CK2 inhibits NMM-II-B filamentation, and that the effect involves direct interaction of the CK2 with the myosin. CK2 is a ubiquitous, pleiotropic, and multifunctional constitutively active serine/threonine protein kinase that is expressed in most eukaryotic cells, 39 · 4 " included in CaSki cells. Although there are more than 300 documented substrates for CK2, most are involved in gene expression, protein synthesis, and signaling, but only a few in the regulation of the cytoskeleton, 40 and only two reports documented the involvement of myosin II in smooth muscle cells. 41 • 42 NMM-II-HC-B contains phosphorylation sites for CK2, 21 • 43 and the filamentation effect of CK2 is possibly mediated by a direct increase in phosphorylation of NNM-II-B. The present data show for the first time that NMM-II-B of epithelial cells is a CK2 substrate. This conclusion is of interest given the known role of CK2 in cell survival, growth, and proliferation, 40 which require modulation of the cytoskeleton into a dynamic structure.
An additional objective of the study was to understand how modulation ofNMM-II-B regulates the paracellular resistance. The results showed that DRB and Y-27632 modulated the Rus• and that their effects were distinct from those of phalloidin and SNP, which modulate the Rus through modulation of cellular F-actin/G-actin status. 5 The present data suggest that NMM-II-B regulation of the Rus utilizes a different mechanism. This statement is supported by the following data: (1) both DRB and phalloidin increased the resistance, and the combined effects of DRB plus low concentrations of phalloidin were additive; (2) SNP decreased the resistance, and the combined effects of DRB plus SNP were additive; (3) treatment with DRB did not affect cellular G-actin; and (4) cotreatment with phalloidin had no significant effect on the increases in NMM-II-B phosphorylation induced by Y-27632 or okadaic acid.
The present and our previous data 17 therefore suggest three different modes of paracellular resistance regulation: regulation of RTJ• eg, by ATP; actin regulation of the Rus• eg, by phalloidin; and NMM-II-B regulation of the Rus• eg, by CK2. Hierarchically and quantitatively, RTJ regulation of the RTE is dominant over the Rus effects of actin and NMM-II-B. Thus, ATP phase II effect increased RTE by about 75 n. cm 2 , compared to the phalloidin increase in RTE of about 37 n. cm 2 , and to the DRB increase in RTE of about 15 n. cm 2 (Figure lOB) . While the RTJ effects of ATP were additive to those of the phalloidin and DRB Rus effects, increases in Rus were limited to about 60 0 · cm 2 , which in the present study was the upper limit of Rus that the CaSki epithelium could generate through the combined effects of phalloidin and DRB. Likewise, the upper limit of total paracellular resistance (RTE) that the CaSki epithelium could generate (ie, Rus + RTJ) was about 100 n. cm 2 .
The cytochalasin-D data demonstrated that significant perturbations of the cytoskeletal acto-myosin frame can modifY both the Rus and the RTJ· Cytochalasin-D abrogated the Rus by stimulating degradation of F-actin, 44 • 45 inducing breakage of the cortical cytoskeleton (Figures 2 and 3) , and by decreasing the interaction of actin with NMM-II-B ( Figure 6 ). The structural changes in the cytoskeletal acto-myosin frame could also affect the structure of the tight junctions and the proximity of tight junctions of neighboring cells, and thereby decrease the RTJ (Figure 1) . Phalloidin, an inhibitor ofF-actin depo-
